Conference abstracts

AuthorsTitlePublication/MeetingDateVolumeIssuePages
Guyader J.-M., Bernardin L., Douglas N.H.M., Poot D.H.J., Niessen W.J., Klein S.Influence of image registration on ADC images computed from free-breathing diffusion MRIs of the abdomen.SPIE2014
Guyader J.-M., Bernardin L., Douglas N.H.M., Poot D.H.J., Niessen W.J., Klein S.Influence of image registration on the reproducibility of computed apparent diffusion coefficients in free-breathing diffusion MRI of the abdomen.NVPHBV spring meeting2013
Guyader J.-M., Bernardin L., Douglas N.H.M., Poot D.H.J., Niessen W.J., Klein S.Influence of image registration on the reproducibility of computed apparent diffusion coefficients in free-breathing diffusion MRI of the abdomen.ESMRMB2013
Keen H., Ble F.-X., Gendrin C., Barjat H., Ricketts S.-A.Temporal evolution of apparent diffusion coefficient MRI and [18F]-FLT PET imaging biomarkers in response to gefitinib therapy, Personalised Healthcare and Biomarkers.AstraZeneca, Macclesfield, United Kingdom2013
Douglas N.H.M. , Winfield J.M., deSouza N.M., Collins D.J., Orton M.R.Quality Assurance of Diffusion-Weighted MRI for Multicentre Clinical Trials.2013
Douglas N.H.M. , Winfield J.M., deSouza N.M., Collins D.J., Orton M.R.Development of a Phantom for Quality Assurance in Multi-Centre Clinical Trials with Diffusion-Weighted MRI.2013
Frings V., Schouten R., Velasquez L., Hayes W., van Velden F., Hoekstra O., Boellaard R.Repeatability of metabolically active tumor volume of [18F]FDG PET-CT in a multicenter setting.SNMMI Annual Meeting 2013
Frings V., de Langen J., Yaqub M., Schuit R., van der Veldt A., Hoekstra O., Smit E., Boellaard R.Methodological considerations in full kinetic analysis of [18F]FLT PET in patients with non-small cell lung cancer.SNMMI Annual Meeting 2013
Frings V., Boellaard R., Herder G., Peters G., Honeywell R., Thunnissen F., Hoekstra O., Smit E.Pemetrexed induced thymidylate synthase inhibition in non-small cell lung cancer (NSCLC) in vivo: A pilot study with [18F]FLT PET and clinical outcome.SNMMI Annual Meeting 2012
Witney T.Non-invasive imaging of tumor apoptosis in NSCLC with 17F-ICMT-11 positron emission tomography.2012
Waterton J.C., Lacombe D.QuIC-ConCePT: Quantitative imaging in oncology-connecting cellular processes to therapyEuropean Journal of Cancer20124874
Wachsmuth L., Schäfers S., Viel T., Hermann S., Müller-Tidow C., Schäfers M., Schäfers K., Jacobs A.H., Kremer N., Faber C.Non-invasive correlation of 18F-FLT PET and DW-MRI of human lung carcinoma in a xenograft mouse model.ISMRM, Salt Lake City, Utah, USA2013
Hoyng L.L., Tomasi G., Hoekstra O.S., Lammertsma A.A., Turkheimer F.E., Gray K., Kenny L.M., Abboagye E.O., Boellaard R.Tumour volume segmentation from dynamic [18F]FLT dataEANM2012abstract PW063
Keen H., Ble F.-X., Gendrin C., Barjat H., Ricketts S.-A.Temporal evolution of apparent diffusion coefficient MRI and [18F]-FLT PET imaging biomarkers in response to gefitinib therapy.SNMMI Annual Meeting2013
L. Hoyng et al.Interobserver variability of image derived input functions for noninvasive pharmacokinetic analysis of PET studiesSNM2015
G. Kramer et al.Parametric evaluation of FLT in lung cancer patientsSNM2015
Y. LiuSession III: Precision medicine and imaging

QuIC-ConCePT platform was presented
European Society of Oncology Imaging annual conference 20152015
Y. Liu, NM. deSouza
Joint Session of the ESR and EORTC "Imaging in multicentre clinical oncological trials"

QuIC-ConCePT results of diffusion weighted standardization were presented
European Congress of Radiology 20152015
Accuracy and precision of parametric analysis of dynamic [18F]FLT PET in EGFR-mutated NSCLC patientsNVKF congress (Physicists)2016
Papoutsaki M-V, Weller A, Orton MR, Desouza NMExploring the impact of common sequence variations on ADC reliability of lung lesions prior to protocol implementation in multi-centre clinical trialsISMRM 20162016
Adrien Albert, Jeroen Verhaeghe, Christel Vangestel, Leonie Wyffels, Gem Kramer, Marc Peeters, Tim Van Den Wyngaert, Sigrid Stroobants, Steven StaelensOptimizing ([18F] FLT) 3’deoxy-3’ fluorothymidine PET for the detection and quantification of liver metastases in colorectal cancer patients: a test-retest studySNMMI 20162016

IMI oncology projects